triazoles has been researched along with sphingosine kinase in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anthony, NG; Baek, DJ; Bittman, R; Mackay, SP; MacRitchie, N; Pyne, NJ; Pyne, S | 1 |
Bianco, R; Caliendo, G; Ciciola, P; Cirino, G; Corvino, A; Fiorino, F; Frecentese, F; Incisivo, GM; Magli, E; Perissutti, E; Riemma, MA; Rosa, R; Roviezzo, F; Saccone, I; Santagada, V; Severino, B; Temussi, PA | 1 |
Beltrán-Debón, R; Cardona, A; Castillón, S; Díaz, Y; Escudero-Casao, M; Matheu, MI | 1 |
Abegg, D; Adibekian, A; Childs-Disney, JL; Costales, MG; Disney, MD; Hoch, DG; Velagapudi, SP | 1 |
4 other study(ies) available for triazoles and sphingosine kinase
Article | Year |
---|---|
Structure-activity relationships and molecular modeling of sphingosine kinase inhibitors.
Topics: Benzamides; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Protein Conformation; Quaternary Ammonium Compounds; Structure-Activity Relationship; Triazoles | 2013 |
Development of 1,2,3-Triazole-Based Sphingosine Kinase Inhibitors and Their Evaluation as Antiproliferative Agents.
Topics: Animals; Aorta; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Humans; Male; Mice; Phosphotransferases (Alcohol Group Acceptor); Triazoles; Vasodilator Agents | 2017 |
Fluorinated triazole-containing sphingosine analogues. Syntheses and in vitro evaluation as SPHK inhibitors.
Topics: Chemistry Techniques, Synthetic; Click Chemistry; Enzyme Inhibitors; Halogenation; Phosphotransferases (Alcohol Group Acceptor); Sphingosine; Stereoisomerism; Triazoles | 2018 |
A Designed Small Molecule Inhibitor of a Non-Coding RNA Sensitizes HER2 Negative Cancers to Herceptin.
Topics: Ado-Trastuzumab Emtansine; Antineoplastic Agents; Base Sequence; Benzimidazoles; Cell Line, Tumor; Drug Design; Humans; Lysophospholipids; MicroRNAs; Phosphotransferases (Alcohol Group Acceptor); Proteome; Receptor, ErbB-2; RNA Precursors; Sphingosine; Trastuzumab; Triazoles | 2019 |